Published on in Vol 4, No 1 (2015): Jan-Mar

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial

Ashish Atreja   1 , MPH,MD ;   Sameer Khan   1 , BS ;   Jason D Rogers   1 , BA ;   Emamuzo Otobo   1 , MD ;   Nishant P Patel   1 , MD ;   Thomas Ullman   2 , MD ;   Jean Fred Colombel   2 , MD ;   Shirley Moore   3 , RN,PhD ;   Bruce E Sands   2 , MS,MD ;   HealthPROMISE Consortium Group   1

1 Sinai AppLab, Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States

2 Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States

3 Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, United States

Corresponding Author:

  • Ashish Atreja, MPH,MD
  • Sinai AppLab, Division of Gastroenterology
  • Department of Medicine
  • Icahn School of Medicine at Mount Sinai
  • Mailbox 1469
  • 1468 Madison Avenue
  • New York, NY, 10029
  • United States
  • Phone: 1 212 241 5090
  • Fax: 1 000 000 0000
  • Email: ashish.atreja@mssm.edu